MabVax Therapeutics Holdings Inc. (MBVX) Declined -8.49% or -0.14 To Price $1.51 On Tuesday

MabVax Therapeutics Holdings Inc. (MBVX) declined -8.49% or -0.14 to $1.51. It is nearly 20716 shares traded, which is 58.74% compare to the average total volume 35269. The market cap of MBVX is $13.53 million. The year to date change is -23.61%. The 52 week price range is from $1.05 to $6.09. Price of MBVX have changed 27.91% during last week. It have changed -0.60% over last month, -34.55% over last 3 months, -15.38% over last 6 months and -72.91% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MBVX is 1.54. It is 1.99% above current price. The 200-day Moving Averages for MBVX is 1.99. It is 31.79% above current price. The 52-week High is 6.09. It is 303.31% from the current price. The 52-week Low is 1.05. It is -30.46% from current price.

There are some statistics of MBVX. It is has market cap $13.53 million. The share outstanding is 8.96 million. The average volume is 35269. The percent of top 15 Institution holding is 1.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MBVX is -1331.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MBVX is -291.45%.


Share this post